Volume 34 Number 3 | 2019
- 2020 license and registration renewals;
- Notice - Licensee Portal;
- Welcome to new employees;
- ALBME social media guidelines;
- Starting Nov. 18 Gabapentin will be a Schedule V drug;
- Administrative rule changes;
- Public actions of the Board and Commission.